Literature DB >> 15526169

Proton motive force mediates a reorientation of the cytosolic domains of the multidrug transporter LmrP.

B Gbaguidi1, P Mazurkiewicz, W N Konings, A J M Driessen, J M Ruysschaert, C Vigano.   

Abstract

LmrP from Lactococcus lactis is a 45-kDa membrane protein that confers resistance to a wide variety of lipophilic compounds by acting as a proton motive force-driven efflux pump. This study shows that both the proton motive force and ligand interaction alter the accessibility of cytosolic tryptophan residues to a hydrophilic quencher. The proton motive force mediates an increase of LmrP accessibility toward the external medium and results in higher drug binding. Residues Asp128 and Asp68, from cytosolic loops, are involved in the proton motive force-mediated accessibility change. Ligand binding does not modify the protein accessibility, but the proton motive force-mediated restructuring is prerequisite for a subsequent accessibility change mediated by ligand binding. Asp142 cooperates with other membrane-embedded carboxylic residues to promote a conformational change that increases LmrP accessibility toward the hydrophilic quencher. This drug binding-mediated reorganization may be related to the transition between the high- and low-affinity drug-binding sites and is crucial for drug release in the extracellular medium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526169     DOI: 10.1007/s00018-004-4298-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  8 in total

Review 1.  Energy coupling mechanisms of MFS transporters.

Authors:  Xuejun C Zhang; Yan Zhao; Jie Heng; Daohua Jiang
Journal:  Protein Sci       Date:  2015-09-18       Impact factor: 6.725

2.  Lipids modulate the conformational dynamics of a secondary multidrug transporter.

Authors:  Chloé Martens; Richard A Stein; Matthieu Masureel; Aurélie Roth; Smriti Mishra; Rosie Dawaliby; Albert Konijnenberg; Frank Sobott; Cédric Govaerts; Hassane S Mchaourab
Journal:  Nat Struct Mol Biol       Date:  2016-07-11       Impact factor: 15.369

3.  Protonation drives the conformational switch in the multidrug transporter LmrP.

Authors:  Matthieu Masureel; Chloé Martens; Richard A Stein; Smriti Mishra; Jean-Marie Ruysschaert; Hassane S Mchaourab; Cédric Govaerts
Journal:  Nat Chem Biol       Date:  2013-12-08       Impact factor: 15.040

4.  Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.

Authors:  Ilana Lopes Baratella da Cunha Camargo; Hui-Min Neoh; Longzhu Cui; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

Review 5.  Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier.

Authors:  Helen I Zgurskaya; Valentin V Rybenkov; Ganesh Krishnamoorthy; Inga V Leus
Journal:  Res Microbiol       Date:  2018-02-16       Impact factor: 3.992

6.  Structure and pH-induced structural rearrangements of the putative multidrug efflux pump EmrD in liposomes probed by site-directed spin labeling.

Authors:  P Ryan Steed; Ping Zou; Kristin E Trone; Hassane S Mchaourab
Journal:  Biochemistry       Date:  2013-11-01       Impact factor: 3.162

7.  Basic residues R260 and K357 affect the conformational dynamics of the major facilitator superfamily multidrug transporter LmrP.

Authors:  Wei Wang; Hendrik W van Veen
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

8.  Hoechst 33342 Is a Hidden "Janus" amongst Substrates for the Multidrug Efflux Pump LmrP.

Authors:  Arthur Neuberger; Hendrik W van Veen
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.